“The stunning epidemiology and clinical features of COVID-19, particularly the potential for explosive and asymptomatic spread, increase the chance that a vaccine may actually be required to end this epidemic,” […]
BIOQUAL announces the development of programs for in-vivo testing of COVID-19 candidate vaccines. BIOQUAL’s efforts to develop animal models for COVID-19 began in February 2020 in collaboration with Dr. Dan […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/NPR.png16381638Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2020-03-30 22:13:462020-03-31 08:55:37WBUR’s All Things Considered Broadcast: March 30, 2020
https://cvvr.hms.harvard.edu/wp-content/uploads/2019/12/CVVR-square-350px.png351351Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2020-03-30 15:01:302020-03-31 08:55:03Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/04/Boston-globe.jpg240240Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2020-03-30 14:56:322020-04-20 12:44:41US and J & J commit $1b to coronavirus vaccine codeveloped by Beth Israel
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/Capture.jpg408493Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2020-03-27 14:46:432020-03-31 14:52:01Here are some of the Mass. businesses and institutions on the front lines of the COVID-19 battle
“And, logically, the larger amount of virus should trigger more severe disease by prompting a brisker inflammatory response. But that is still speculative. The relationship between initial viral dose and […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/the-new-yorker.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2020-03-26 13:09:572020-05-14 09:09:49How Does the Coronavirus Behave Inside a Patient?
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/NBC.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2020-03-25 16:52:362020-05-14 09:11:33Beth Israel Launches Drug Study to Help COVID-19 Patients
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/croi_w360.png166360Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2020-03-24 12:39:432020-04-06 12:40:40HIV cure at CROI: new data on antibodies, vaccines and genetically engineered T-cells
Dr. Dan Barouch, head of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, welcomed the possibility of the government speeding approval of a coronavirus vaccine. […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/04/Boston-globe.jpg240240Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2020-03-23 11:46:522020-05-14 09:25:33Moderna might seek emergency approval this fall of coronavirus vaccine for health care workers
Ending the Pandemic
/in News“The stunning epidemiology and clinical features of COVID-19, particularly the potential for explosive and asymptomatic spread, increase the chance that a vaccine may actually be required to end this epidemic,” […]
BIOQUAL Announces COVID-19 Vaccine Testing
/in NewsBIOQUAL announces the development of programs for in-vivo testing of COVID-19 candidate vaccines. BIOQUAL’s efforts to develop animal models for COVID-19 began in February 2020 in collaboration with Dr. Dan […]
WBUR’s All Things Considered Broadcast: March 30, 2020
/in NewsDr. Dan Barouch speaks with Lisa Mullins from WBUR about COVID-19 vaccine plans with Johnson & Johnson. Listen more
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19
/in NewsUS and J & J commit $1b to coronavirus vaccine codeveloped by Beth Israel
/in NewsClinical trials are set to start by September, and if all goes well, it could be ready for emergency use early next year. Read Article
Here are some of the Mass. businesses and institutions on the front lines of the COVID-19 battle
/in News“The industry in Massachusetts is going to the mat to fight this thing.” Read Article
How Does the Coronavirus Behave Inside a Patient?
/in News“And, logically, the larger amount of virus should trigger more severe disease by prompting a brisker inflammatory response. But that is still speculative. The relationship between initial viral dose and […]
Beth Israel Launches Drug Study to Help COVID-19 Patients
/in NewsDr. Katy Stephenson speaks to NBC Boston about leading two clinical trials for a treatment for COVID-19 patients. See more
HIV cure at CROI: new data on antibodies, vaccines and genetically engineered T-cells
/in NewsPre-conference Community HIV Cure Research Workshop outlines the results. Read Article
Moderna might seek emergency approval this fall of coronavirus vaccine for health care workers
/in NewsDr. Dan Barouch, head of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, welcomed the possibility of the government speeding approval of a coronavirus vaccine. […]